TY - JOUR
T1 - Metabolic syndrome and prediabetes in ndokwa community of nigeria
T2 - Preliminary study
AU - Nwose, E. U.
AU - Oguoma, V. M.
AU - Bwititi, P. T.
AU - Richards, R. S.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Background: Global prevalence of metabolic syndrome (MS) and diabetes is increasing, but the reference ranges for MS indices have yet to be established for sub-Saharan African countries. As part of the international research collaboration agenda for Prediabetes and Cardiovascular Complications Study (PACCS), a pilot study was conducted in one of the Ndokwa communities of Nigeria in 2013. Aim: The study was to obtain preliminary indication of prevalence and reference values of MS in the rural communities of a low-mid income country. Materials and Methods: Seventy-four volunteer participants were recruited, after public lectures in high schools and churches in the community. Body mass index (BMI), blood pressure and waist circumference (WC), blood glucoselevel, and lipid profi le were measured. Percentage prevalence MS was determined using commonest three criteria (Third Adult Treatment Panel (ATP III) 2001, International Diabetes Federation (IDF) 2005, and World Health Organization (WHO) 1999). Results: When individual indices of MS are considered separately; the males seem healthier than females. However, the prevalence of high-density lipoprotein (HDL) cholesterol was higher in males than in females. Equal 3% prevalence of MS was seen in both genders using the WHO standard. Other criteria show prevalence of 8% females and 11% males (ATP III), 5% females and 8% males (IDF 2005 European), and 14% females and 17% males (IDF 2005 Ethnic). Conclusion: The prevalence of MS is higher in males than females; and relative to ATP III 2001 criteria, either the IDF 2005 European may underestimate MS, or the ethnic specifi c could overestimate the prevalence. Hence, it is important to defi ne the criteria to be used.
AB - Background: Global prevalence of metabolic syndrome (MS) and diabetes is increasing, but the reference ranges for MS indices have yet to be established for sub-Saharan African countries. As part of the international research collaboration agenda for Prediabetes and Cardiovascular Complications Study (PACCS), a pilot study was conducted in one of the Ndokwa communities of Nigeria in 2013. Aim: The study was to obtain preliminary indication of prevalence and reference values of MS in the rural communities of a low-mid income country. Materials and Methods: Seventy-four volunteer participants were recruited, after public lectures in high schools and churches in the community. Body mass index (BMI), blood pressure and waist circumference (WC), blood glucoselevel, and lipid profi le were measured. Percentage prevalence MS was determined using commonest three criteria (Third Adult Treatment Panel (ATP III) 2001, International Diabetes Federation (IDF) 2005, and World Health Organization (WHO) 1999). Results: When individual indices of MS are considered separately; the males seem healthier than females. However, the prevalence of high-density lipoprotein (HDL) cholesterol was higher in males than in females. Equal 3% prevalence of MS was seen in both genders using the WHO standard. Other criteria show prevalence of 8% females and 11% males (ATP III), 5% females and 8% males (IDF 2005 European), and 14% females and 17% males (IDF 2005 Ethnic). Conclusion: The prevalence of MS is higher in males than females; and relative to ATP III 2001 criteria, either the IDF 2005 European may underestimate MS, or the ethnic specifi c could overestimate the prevalence. Hence, it is important to defi ne the criteria to be used.
KW - Cardiovascular disease
KW - Diabetes
KW - Diabetes prevention
KW - Low-mid income communities
KW - Prediabetes and cardiovascular complications study (PACCS)
KW - Public health
UR - http://www.scopus.com/inward/record.url?scp=84923359587&partnerID=8YFLogxK
U2 - 10.4103/1947-2714.152079
DO - 10.4103/1947-2714.152079
M3 - Article
AN - SCOPUS:84923359587
SN - 2250-1541
VL - 7
SP - 53
EP - 58
JO - North American Journal of Medical Sciences
JF - North American Journal of Medical Sciences
IS - 2
ER -